MECHELEN, Belgium, April 1, 2014 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext: GLPG) confirms the completion of the transaction announced on 13 March 2014 to sell the BioFocus and Argenta service division operations to Charles River Laboratories International, Inc. (NYSE: CRL) for a total consideration of up to €134 million.
Help employers find you! Check out all the jobs and post your resume.
